Showing results (121-130 of 198) with videos related to

Sort By:
Pageof 20
Pharmacoeconomics|July 14, 2012
Cost effectiveness of guanfacine extended release as an adjunctive therapy to a stimulant compared with stimulant monotherapy for the treatment of attention-deficit hyperactivity disorder in children and adolescentsVanja Sikirica, M Haim Erder, Jipan Xie, et al.
Crohn'S & Colitis 360|February 13, 2023
Economic Outcomes of Inflammatory Bowel Disease Patients Switching to a Second Anti-Tumor Necrosis Factor or VedolizumabMichael Chiorean, Anita Afzali, Raymond K Cross, et al.
Cancer Cell|June 10, 2015
Kinase and BET Inhibitors Together Clamp Inhibition of PI3K Signaling and Overcome Resistance to TherapyElias E Stratikopoulos, Meaghan Dendy, Matthias Szabolcs, et al.
The Journal of Physical Chemistry. B|July 21, 2006
Molecular hydrogen occupancy in binary THF-H2 clathrate hydrates by high resolution neutron diffractionKeith C Hester, Timothy A Strobel, E Dendy Sloan, et al.
European Journal of Nuclear Medicine|August 1, 1980
A preliminary investigation of 67Ga citrate distribution in hyperferraemic patientsF W Smith, P P Dendy, T Pocklington, et al.
Journal of Gastrointestinal Oncology|May 20, 2021
Burden of illness for patients with cholangiocarcinoma in the United States: a retrospective claims analysisChristina X Chamberlain, Elizabeth Faust, Debbie Goldschmidt, et al.
The Journal of Physical Chemistry. B|July 28, 2011
Xenon hydrate dissociation measurements with model protein systemsRyan D Booker, Carolyn A Koh, E Dendy Sloan, et al.
Advances in Therapy|April 1, 2019
Economic Burden of Illness Among Commercially Insured Patients with Systemic Sclerosis with Interstitial Lung Disease in the USA: A Claims Data AnalysisZhou Zhou, Yanni Fan, Darren Thomason, et al.
Current Medical Research and Opinion|March 18, 2016
Comparison of real-world outcomes of adalimumab and infliximab for patients with ulcerative colitis in the United StatesWilliam J Sandborn, Atsushi Sakuraba, Anthony Wang, et al.
Clinical Therapeutics|June 27, 2015
Costs and Resource Utilization Associated With Anemia and Rash in Chronic Hepatitis C Patients Treated With Direct-Acting Antiviral Agents in the United StatesT Kim Le, Dendy Macaulay, Anupama Kalsekar, et al.
Pageof 20